genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Regeneron
Drug Discovery
StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer
Alex Philippidis
-
August 11, 2023
0
Bioprocessing
Effective IoT Infrastructure Critical for Digital Drug Firms
John Sterling
-
July 12, 2023
0
A-Lists
Top 25 Biotech Companies of 2023
Alex Philippidis
-
May 5, 2023
20
Genome Editing
Molecular Scissors Are Making the Cut … in Clinical Trials
Kathy Vuksanaj
-
May 3, 2023
0
GEN Edge
StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron
Alex Philippidis
-
March 31, 2023
0
Artificial Intelligence
Double Dare: Exscientia Expands AI Platform into Antibody Design
Alex Philippidis
-
November 29, 2022
0
GEN Edge
Supreme Court Grapples with the Enablement Standard for Functional Genus Patent Claims
Alex Philippidis
-
November 14, 2022
0
Cancer
StockWatch: Investors Weigh Genome Editing after Clinical Hold, Patient Death
Alex Philippidis
-
November 10, 2022
0
Insights
New Labs, New Funds: Activity Blossoms in the Leading U.S. Biopharma Clusters
Alex Philippidis
-
August 9, 2022
0
Cancer
StockWatch: Checkmate Shares Quadruple on Regeneron Buyout
Alex Philippidis
-
April 22, 2022
0
1
2
3
...
11
Page 1 of 11
Scroll Up